Josh Memon

Vice President
Chicago Mergers & Acquisitions Healthcare +1 (312) 628-1548
I am driven by supporting healthcare clients achieve growth and innovation, benefiting patients and their families.

Josh provides mergers and acquisitions (M&A) advisory to healthcare companies across various sectors, including post-acute, hospital outsourcing, consumer health and lab services. He is focused on buy-side and sell-side transactions for private equity firms and public and privately held companies located in the United States, Europe and Asia.

Josh works closely with clients to understand their business and goals, allowing him to apply deep healthcare and investment banking expertise to drive successful outcomes.

Prior to Lincoln, Joshua held roles in the M&A and restructuring practices at Hammond Hanlon Camp and Riveron. Josh began his career at Cantor Fitzgerald as an analyst in its corporate finance management program.

Josh earned a Bachelor of Science from Fordham University.

Related Perspectives in Healthcare

Lincoln International’s Global Healthcare Group Announces Strong Results in 2022

Lincoln International’s global Healthcare Group enjoyed another consecutive year of record-setting mergers and acquisitions (M&A) deal volume, average deal size and a record backlog heading in to 2023. Our performance… Read More

Scrip | What Does 2023 Hold for Biopharma? Part 6: Artificial Intelligence

Originally posted by Scrip on February 10, 2023. Tony Crisman, Managing Director in Lincoln’s Healthcare Group, shares his predictions for artificial intelligence in the biopharma industry. View the original article.

2022 Global Results

In 2022, Lincoln International continued to design and deliver meaningful solutions and outcomes for clients around the world. Our shared ambition for results achieved through collaboration, thoughtfulness and tailored approaches… Read More

Lincoln International Announces Managing Director Promotions 2022

Lincoln International, a global investment banking advisory firm, is pleased to announce the promotion of six Directors to Managing Director (MD), effective January 1, 2023. “Each of these individuals contributes… Read More

Showing 1 – 4 of 90
Load More

Meet our Senior Team in Healthcare

Firm details on FINRA’s BrokerCheck